• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

III期黑色素瘤患者淋巴结清扫范围的预后影响

The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma.

作者信息

Galliot-Repkat C, Cailliod R, Trost O, Danino A, Collet E, Lambert D, Vabres P, Dalac S

机构信息

Department of Dermatology, University Hospital, 2 Boulevard Marechal de Lattre de Tassigny, F-21033 Dijon, France.

出版信息

Eur J Surg Oncol. 2006 Sep;32(7):790-4. doi: 10.1016/j.ejso.2006.04.004. Epub 2006 Jul 5.

DOI:10.1016/j.ejso.2006.04.004
PMID:16822643
Abstract

AIMS

To analyse disease-free and overall survival in 67 melanoma patients who underwent dissection for clinically apparent regional lymph node metastases, taking into account the total number of excised lymph nodes.

METHODS

After a median follow-up time of 16 months, 47 recurrences were observed and 43 patients died. The median disease-free and overall survival intervals were 14 and 24 months respectively.

RESULTS

Multivariate analyses revealed that the number of excised lymph nodes had a significant impact on overall survival (P=0.036) but not on disease-free survival (P=0.97). Extranodal growth was the only statistically significant prognostic factor both for disease-free (P=0.005) and overall (P=0.038) survival. Age, nodal basin, primary tumor ulceration, tumor thickness and number of positive lymph nodes were not significant prognostic factors.

CONCLUSIONS

Our results suggest that the total number of lymph nodes excised in the dissection has impact on overall survival of stage III melanoma patients and should be considered in clinical assays.

摘要

目的

分析67例因临床明显的区域淋巴结转移而接受清扫术的黑色素瘤患者的无病生存期和总生存期,并考虑切除淋巴结的总数。

方法

中位随访时间为16个月后,观察到47例复发,43例患者死亡。无病生存期和总生存期的中位间隔分别为14个月和24个月。

结果

多因素分析显示,切除淋巴结的数量对总生存期有显著影响(P = 0.036),但对无病生存期无显著影响(P = 0.97)。结外生长是无病生存期(P = 0.005)和总生存期(P = 0.038)唯一具有统计学意义的预后因素。年龄、淋巴结区域、原发肿瘤溃疡、肿瘤厚度和阳性淋巴结数量不是显著的预后因素。

结论

我们的结果表明,清扫术中切除淋巴结的总数对III期黑色素瘤患者的总生存期有影响,应在临床分析中予以考虑。

相似文献

1
The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma.III期黑色素瘤患者淋巴结清扫范围的预后影响
Eur J Surg Oncol. 2006 Sep;32(7):790-4. doi: 10.1016/j.ejso.2006.04.004. Epub 2006 Jul 5.
2
The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).前哨淋巴结黑色素瘤阳性患者在完成淋巴结清扫术后的生存获益可能仅限于原发灶Breslow厚度大于1.0且小于或等于4mm(pT2-pT3)的亚组。
Ann Surg Oncol. 2008 Aug;15(8):2223-34. doi: 10.1245/s10434-008-9965-3. Epub 2008 May 28.
3
Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.盆腔淋巴结清扫术对淋巴结阳性黑色素瘤患者的某些亚组有益。
Ann Surg Oncol. 2007 Oct;14(10):2867-75. doi: 10.1245/s10434-007-9512-7. Epub 2007 Aug 1.
4
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].[黑色素瘤前哨淋巴结活检:300例患者的预后价值及缺点]
Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1845-51.
5
Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.III期黑色素瘤的分子和生化检测:淋巴结清扫术后淋巴液的多标志物逆转录聚合酶链反应检测及术前血清乳酸脱氢酶水平
Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.
6
Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.皮肤黑色素瘤患者前哨淋巴结活检结果为假阴性的生存分析及临床病理因素
Ann Surg Oncol. 2006 Dec;13(12):1655-63. doi: 10.1245/s10434-006-9066-0. Epub 2006 Oct 3.
7
N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.N比率:III期皮肤黑色素瘤患者的一种新型独立预后因素。
Ann Surg Oncol. 2008 Jan;15(1):310-5. doi: 10.1245/s10434-007-9641-z. Epub 2007 Nov 7.
8
Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.黑色素瘤伴可触及腹股沟淋巴结转移患者的预后及外科治疗
Br J Surg. 2000 Jul;87(7):892-901. doi: 10.1046/j.1365-2168.2000.01439.x.
9
Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.皮肤黑色素瘤前哨淋巴结活检:一项病例对照研究。
Ann Surg Oncol. 2007 Dec;14(12):3566-74. doi: 10.1245/s10434-007-9606-2. Epub 2007 Oct 9.
10
Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.前哨淋巴结中的孤立肿瘤细胞影响黑色素瘤患者的长期预后。
Ann Surg Oncol. 2007 Oct;14(10):2861-6. doi: 10.1245/s10434-007-9472-y. Epub 2007 Jul 18.

引用本文的文献

1
Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.淋巴结比率对 III 期黑色素瘤患者的复发和结局有影响。
Int J Clin Oncol. 2019 Jun;24(6):721-726. doi: 10.1007/s10147-019-01410-4. Epub 2019 Feb 20.
2
Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients.黑色素瘤患者行保留大隐静脉的腹股沟淋巴结清扫术后的发病率及肿瘤学结局
World J Surg Oncol. 2017 May 11;15(1):99. doi: 10.1186/s12957-017-1164-x.
3
Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.
黑色素瘤患者微创腹股沟淋巴结清扫术的安全性与可行性(SAFE-MILND):一项前瞻性多机构试验报告
Ann Surg. 2017 Jan;265(1):192-196. doi: 10.1097/SLA.0000000000001670.
4
Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.III 期皮肤黑色素瘤的浅表和深部淋巴结清扫:临床结果和预后因素。
World J Surg Oncol. 2013 Feb 4;11:36. doi: 10.1186/1477-7819-11-36.
5
Unexpected Long Survival in Primary Malignant Melanoma of the Male Urethra.男性尿道原发性恶性黑色素瘤意外的长期生存
Case Rep Dermatol. 2009 Nov 20;1(1):93-99. doi: 10.1159/000256663.
6
Lymph node ratio predicts disease-specific survival in melanoma patients.淋巴结比率可预测黑色素瘤患者的疾病特异性生存率。
Cancer. 2009 Jun 1;115(11):2505-13. doi: 10.1002/cncr.24290.